This discovery could aid global efforts to combat antibiotic resistance and foster innovative therapeutic approaches.

The findings will significantly contribute to research on bacterial-drug interactions and highlight the center's growing reputation for scientific research and patient care.

Whole-genome sequencing was instrumental in diagnosing and treating bacterial infections, particularly in critical environments and among immunocompromised patients.

A new bacterial species, named riyadhensis, was discovered at a hospital's intensive care unit in 2019.

Initially thought to be a variant of pseudomonas aeruginosa, further analysis using Whole Genome Sequencing (WGS) revealed that it belonged to the stenotrophomonas family instead.

Riyadhensis had distinct genetic and morphological traits, making it unique from any other scientifically recognized members.

The discovery was considered substantial progress in combating antibiotic resistance, developing pharmaceuticals, and preventing disease spread.

Dr. Ahmad Al-Qahtani, head of the center's infectious disease and immunity department, emphasized the importance of WGS analysis in accurate identification and understanding resistance mechanisms during disease outbreak investigations and patient care improvements.

Traditional identification methods may lead to misidentification, making WGS analysis a more precise and targeted approach.

Dr. Reem Almaghrabi, an expert in transplant infectious diseases, emphasized the significance of a recent discovery using Whole Genome Sequencing (WGS) for faster and more accurate diagnosis of bacterial infections.

This approach lays the foundation for international scientific collaboration and strengthens global efforts against antibiotic resistance.

Understanding new bacterial species and their antibiotic resistance is essential in modern healthcare to combat bacterial infections.

With bacteria constantly evolving resistance, they pose a continuous threat to human health.